Longview Partners (Guernsey) LTD Pfizer Inc Transaction History

Longview Partners (Guernsey) LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $320 Million - $352 Million	-8,533,041 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$38.47 - $43.86 $634 Million - $723 Million	-16,483,943 Reduced 65.89%	8,533,041 $372 Million
Q3 2018 Oct 19, 2018	SELL	$34.47 - $41.81 $17.3 Million - $21 Million	-502,400 Reduced 1.97%	25,016,984 $1.1 Billion
Q2 2018 Aug 01, 2018	SELL	$32.98 - $35.16 $9.09 Million - $9.69 Million	-275,619 Reduced 1.07%	25,519,384 $926 Million
Q1 2018 Apr 16, 2018	SELL	$31.91 - $37.02 $1.89 Million - $2.2 Million	-59,349 Reduced 0.23%	25,795,003 $915 Million
Q4 2017 Feb 06, 2018	BUY	$33.26 - $35.29 $49.4 Million - $52.4 Million	1,484,680 Added 6.09%	25,854,352 $936 Million
Q3 2017 Oct 30, 2017	BUY	$31.0 - $34.15 $755 Million - $832 Million	24,369,672	24,369,672 $870 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Longview Partners (Guernsey) LTD, based on Form 13F filings with the SEC.

Stay updated on Longview Partners (Guernsey) LTD with notifications on news.